store at low temperature
store at -80°C
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1). Lorvotuzumab can be used to synthesize antibody-drug conjugate (Lorvotuzumab mertansine).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 368.00 | |
5 mg | In stock | $ 963.00 | |
10 mg | In stock | $ 1,530.00 | |
25 mg | In stock | $ 2,290.00 | |
50 mg | In stock | $ 2,970.00 | |
100 mg | In stock | $ 4,180.00 |
Description | Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1). Lorvotuzumab can be used to synthesize antibody-drug conjugate (Lorvotuzumab mertansine). |
In vitro | Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate (ADC) that utilizes a disulfide linker to connect the potent anti-mitotic agent DM1 to the CD56-targeting antibody (Lorvotuzumab). Lorvotuzumab mertansine is effective against Wilms' tumor, rhabdomyosarcoma, and neuroblastoma. |
Molecular Weight | N/A |
CAS No. | 339306-30-8 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
lorvotuzumab 339306-30-8 Others inhibitor inhibit